Content
02/11/2025 London United Kingdom
Modern Synthesis completed $5.5 million Venture Round funding. Investors include Extantia (lead), Artesian, Collaborative Fund.
#Biotech  #Materials  
About
Modern Synthesis is a London-based biotech company bringing life to new materials. We work with bacteria to produce an entirely new class of nanocellulose-based materials which offer performance without plastics and aesthetics without animal inputs, designed for applications within fashion and beyond.
Startup
Modern Synthesis
https://www.modernsynthesis.com Claim Profile
Location:
London United Kingdom
Sector:
Biotech
Materials
Download StockFan App Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.